PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för raloxifene hydrochloride. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

11 hits

Bibliografisk träff 2014-10-27

Raloxifene hydrochloride treatment leads to better outcomes than medroxyprogesterone acetate when paired with estrogen in ovariectomized cholesterol-fed rabbits.

Zeng C, Yang F, He H, Hu K, Wang X, Hu Q, Li J.

Acta Biochim Biophys Sin (Shanghai) · research support, non-u.s. gov't; journal article · DOI 10.1093/abbs/gmu098

Bibliografisk träff 2014-09-12

Experimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal application.

Mahmood S, Taher M, Mandal UK.

Int J Nanomedicine · research support, non-u.s. gov't; research-article; journal article · DOI 10.2147/ijn.s65408

Bibliografisk träff 2014-07-19

Effect of raloxifene hydrochloride on bone mineral density and bone turnover in Kuwaiti postmenopausal women with osteoporosis.

Abdelazim IA, Abdelrazak KM, Al-Kadi M, Yehia AH, Nusair BM, Faza MA.

Arch Osteoporos · journal article · DOI 10.1007/s11657-014-0189-9

Bibliografisk träff 2013-10-20

Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability.

Kushwaha AK, Vuddanda PR, Karunanidhi P, Singh SK, Singh S.

Biomed Res Int · research support, non-u.s. gov't; research-article; journal article · DOI 10.1155/2013/584549

Bibliografisk träff 2013-01-01

Raloxifene hydrochloride as hepatitis C treatment.

Motola-Kuba M, Méndez-Sánchez N.

Ann Hepatol · comment; journal article · DOI 10.1016/s1665-2681(19)31402-4

Bibliografisk träff 2012-08-10

Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hepatitis C: a randomized trial.

Furusyo N, Ogawa E, Sudoh M, Murata M, Ihara T, Hayashi T, Ikezaki H, Hiramine S, Mukae H, Toyoda K, Taniai H, Okada K, Kainuma M, Kajiwara E, Hayashi J.

J Hepatol · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1016/j.jhep.2012.08.003

Bibliografisk träff 2012-07-18

Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal.

Elsheikh MA, Elnaggar YS, Gohar EY, Abdallah OY.

Int J Nanomedicine · research-article; journal article · DOI 10.2147/ijn.s33186

Bibliografisk träff 2011-05-12

Bioadhesive microspheres for bioavailability enhancement of raloxifene hydrochloride: formulation and pharmacokinetic evaluation.

Jha RK, Tiwari S, Mishra B.

AAPS PharmSciTech · comparative study; research support, non-u.s. gov't; research-article; journal article · DOI 10.1208/s12249-011-9619-9

Bibliografisk träff 2002-04-01

Environmental fate and chemistry of raloxifene hydrochloride.

Teeter JS, Meyerhoff RD.

Environ Toxicol Chem · journal article · DOI 10.1002/etc.5620210407

Bibliografisk träff 2000-09-01

Raloxifene hydrochloride.

Snyder KR, Sparano N, Malinowski JM.

Am J Health Syst Pharm · review; journal article · DOI 10.1093/ajhp/57.18.1669

Bibliografisk träff 1999-01-01

Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women.

Nickelsen T, Lufkin EG, Riggs BL, Cox DA, Crook TH.

Psychoneuroendocrinology · clinical trial, phase ii; clinical trial; multicenter study; randomized controlled trial; journal article · DOI 10.1016/s0306-4530(98)00041-9